Covetrus Stock Price, News & Analysis
Company Description
Covetrus (NASDAQ: CVET) is a publicly traded medical distribution company in the Healthcare sector. The company has a market capitalization of $2.9B.
CVET stock has gained 13.3% over the past year.
This page provides a comprehensive overview of CVET stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Covetrus (CVET) stock. Over the past 12 months, the stock has gained 13.3%. At a market capitalization of $2.9B, CVET is classified as a mid-cap stock with approximately 140.1M shares outstanding.
Latest News
Covetrus has 10 recent news articles. Of the recent coverage, 4 articles coincided with positive price movement and 2 with negative movement. Key topics include management, earnings, acquisition. View all CVET news →
SEC Filings
Financial Highlights
Upcoming Events
Settlement hearing
Covetrus has 1 upcoming scheduled event. The next event, "Settlement hearing", is scheduled for April 13, 2026 (in 9 days). Investors can track these dates to stay informed about potential catalysts that may affect the CVET stock price.
Short Interest History
Days to Cover History
CVET Company Profile & Sector Positioning
Covetrus (CVET) operates in the Medical Distribution industry within the broader Healthcare sector and is listed on the NASDAQ.
Investors comparing CVET often look at related companies in the same sector, including Henry Schein, Inc. (HSIC), Clinigen Group (CGNGY), AKSO HEALTH GROUP (AHG), Owens & Minor (OMI), and Cencora Inc. (COR). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate CVET's relative position within its industry.